Intraocular injection of tamoxifen-loaded nanoparticles: a new treatment of experimental autoimmune uveoretinitis. - Wikidata - wikimedia - TriplyDB

Intraocular injection of tamoxifen-loaded nanoparticles: a new treatment of experimental autoimmune uveoretinitis.

Intraocular injection of tamoxifen-loaded nanoparticles: a new treatment of experimental autoimmune uveoretinitis.

http://www.wikidata.org/entity/Q42166603

about

Prospects and applications of nanobiotechnology: a medical perspective Drug delivery to the posterior segment of the eye for pharmacologic therapy.The effects of tamoxifen on immunity.Profile of differentially expressed intratumoral cytokines to predict the immune-polarizing side effects of tamoxifen in breast cancer treatment Nanotechnology and nanotoxicology in retinopathy.Sustained release intraocular drug delivery devices for treatment of uveitis Ocular and systemic bio-distribution of rhodamine-conjugated liposomes loaded with VIP injected into the vitreous of Lewis rats.Novel approaches to retinal drug delivery.Ocular drug delivery: nanomedicine applications.Design aspects of poly(alkylcyanoacrylate) nanoparticles for drug delivery.A relevant in vitro rat model for the evaluation of blood-brain barrier translocation of nanoparticles.The future of uveitis treatment Toxicity of nanomaterials to the eye.Intravitreal devices for the treatment of vitreous inflammation.Nanoparticles in the ocular drug delivery.Drug delivery implants in the treatment of vitreous inflammation Nanocarriers for ocular delivery for possible benefits in the treatment of anterior uveitis: focus on current paradigms and future directions.Nanocarriers of nanotechnology in retinal diseases.Nanocarrier mediated retinal drug delivery: overcoming ocular barriers to treat posterior eye diseases.Magnetic nanoparticles: a strategy to target the choroidal layer in the posterior segment of the eye Antibody neutralization poses a barrier to intravitreal adeno-associated viral vector gene delivery to non-human primates Diffusion Regulation in the Vitreous Humor.Investigation of nanoparticles using magnetic resonance imaging after intravitreal injection.Quantum dot-loaded PEGylated poly(alkyl cyanoacrylate) nanoparticles for in vitro and in vivo imaging Partial mitigation of gold nanoparticle interactions with human lymphocytes by surface functionalization with a ‘mixed matrix’

P2860

Q28387616-4D0123AD-15AB-4540-B577-BBB5A848A2FA Q30478379-94B217A0-A795-46E1-91CB-1B8409E85FAF Q33989185-CEBE750E-D325-4C6B-832B-960638437AAB Q35402584-99DA8A00-D0CF-4161-BA91-59DBA0D27E4D Q35600266-712685FB-CA0D-49FB-82B7-48D0A9BB1668 Q35835614-0E889DB4-A5AD-4D36-B730-6C07C86FCD61 Q36498879-5B69C13B-69D1-478C-A7F9-040312CA454D Q36903801-5EB2B7E3-DAAC-4BC5-8BBF-0CEDFFB9D7C9 Q36918036-ADACAC9E-DC4C-4C1F-98B0-7A50537C9E58 Q37015849-E4501048-87DE-402A-B220-116BD589A346 Q37413195-3219686A-5BCF-4454-8954-7E021D524EDB Q37554382-0DFA722A-6E39-4CD2-BF88-13EAA534B6B5 Q37676123-8379BCE9-F9C8-4281-A101-29EF41109D4B Q38044373-A1E5AB83-C5C7-496D-A740-44F7EB31A378 Q38119238-905A05D2-D406-44E9-82DB-27D18B30669D Q38160003-F183139F-B2FA-485C-A01E-156EF516117A Q38227621-08441776-7AF1-4B37-A267-0F22691B5B28 Q38282885-FC3CE47B-AD37-4F5B-81F9-A1AF544A2319 Q38829320-2D66200F-8A3A-4EE6-8D17-3CFA1AF79FCB Q38931354-56FDAF17-D135-418F-A3AD-55118DC96944 Q39076892-63B3DE94-0D37-484C-B83B-791417E2EA05 Q41946889-6F3853C1-3281-4672-82B2-E63743529411 Q49064827-6E5FFD37-F2E6-4574-8687-37AAADA47A08 Q57676504-9BF0A7F3-39C0-4F16-8B19-67BD81ADEFF1 Q58073566-FAA6E384-B916-4FA9-8B80-AACE862B5326

P2860

Intraocular injection of tamoxifen-loaded nanoparticles: a new treatment of experimental autoimmune uveoretinitis.

http://www.wikidata.org/entity/Q42166603

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

2004年论文

@zh

2004年论文

@zh-cn

name

Intraocular injection of tamox ...... ntal autoimmune uveoretinitis.

@en

Intraocular injection of tamox ...... ntal autoimmune uveoretinitis.

@nl

type

label

Intraocular injection of tamox ...... ntal autoimmune uveoretinitis.

@en

Intraocular injection of tamox ...... ntal autoimmune uveoretinitis.

@nl

prefLabel

Intraocular injection of tamox ...... ntal autoimmune uveoretinitis.

@en

Intraocular injection of tamox ...... ntal autoimmune uveoretinitis.

@nl

P1433

Q42166603-452A5A2C-55EC-4E90-B4D0-B51C01481873

P1476

Q42166603-5B21ADB9-7C1D-41D9-85B8-B5510288E6F4

P2093

Q42166603-41B7DC6B-EAC7-404E-BA98-A3DE96B2688A

Q42166603-9D8A9EAB-B443-4870-8980-8DFDA29ECD85

Q42166603-BE6FCCA8-CEE1-436F-BA14-ACD7CD162A42

Q42166603-E38C9633-CAAA-4C03-97AA-FB9F625CADBF

Q42166603-E9C41349-1DA9-43C2-8CA4-18970AE63C47

Q42166603-F1284694-FC1D-4DEC-96A6-B016B84810A2

P2860

Q42166603-00D7A1CE-C479-4940-B417-98F17FB8D29A

Q42166603-2F3E4578-B708-4A84-B3AA-4C821FE6477B

Q42166603-77D1EF0D-70D5-4E91-9000-D54EECFE2A42

Q42166603-FD8C4A8E-DBAA-46B9-8E71-9160F3CB2080

P304

Q42166603-9F40A771-531C-4744-B74C-8376A4EAAE1E

P31

Q42166603-DD516CD9-0C08-4291-BF89-2D4DF60B347D

P356

Q42166603-B4C11C4E-0183-4126-B7DB-7ACE182D851B

P407

Q42166603-AC74F1CB-F86D-401B-8021-C852B13663D9

P433

Q42166603-8B5B0876-031A-43A1-BEFD-801B80620EA9

P478

Q42166603-54C6C283-6456-4F28-80B2-045DA3D22663

P50

Q42166603-E6FEA5B6-E91A-469B-A3B2-3C3BE0018BFE

Q42166603-FF063C5B-CD41-4945-92BF-54F35FA01681

P577

Q42166603-503C7447-5D90-4D59-A3F0-20071C95CD43

P5875

Q42166603-25D07F23-D9CC-4DD1-B550-A3A45E00754D

P698

Q42166603-960246AB-C0AE-446A-9F6D-489D58B31965

P921

Q42166603-ECE5D4D2-DC5F-4418-80D7-6EA0EA92D2D6

P356

P1433

European Journal of Immunology

P1476

Intraocular injection of tamox ...... ntal autoimmune uveoretinitis.

@en

P2093

Brigitte Thillaye-Goldenberg

http://www.w3.org/2001/XMLSchema#string

Christophe Klein

http://www.w3.org/2001/XMLSchema#string

Elisabeth Garcia

http://www.w3.org/2001/XMLSchema#string

Henri Villarroya

http://www.w3.org/2001/XMLSchema#string

Marie-Christine Naud

http://www.w3.org/2001/XMLSchema#string

Yvonne de Kozak

http://www.w3.org/2001/XMLSchema#string

P2860

Low-dose estrogen therapy ameliorates experimental autoimmune encephalomyelitis in two different inbred mouse strains.

Oral feeding with ethinyl estradiol suppresses and treats experimental autoimmune encephalomyelitis in SJL mice and inhibits the recruitment of inflammatory cells into the central nervous system.

APCs in the anterior uveal tract do not migrate to draining lymph nodes.

The distribution of antigen in lymphoid tissues following its injection into the anterior chamber of the rat eye.

P304

3702-3712

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/EJI.200425022

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

34

http://www.w3.org/2001/XMLSchema#string

P50

Patrick Couvreur

Karine Andrieux

P577

2004-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8202043

http://www.w3.org/2001/XMLSchema#string

P698

15517615

http://www.w3.org/2001/XMLSchema#string

P921